Detalles de la búsqueda
1.
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Clin Infect Dis
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598658
2.
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
N Engl J Med
; 385(25): 2348-2360, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587382
3.
Statistical design and analysis of controlled human malaria infection trials.
Malar J
; 23(1): 133, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38702775
4.
Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2.
Am J Epidemiol
; 192(6): 1016-1028, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883907
5.
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial.
Ann Intern Med
; 175(9): 1258-1265, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35785530
6.
Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Clin Infect Dis
; 74(3): 544-552, 2022 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34260716
7.
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
Ann Intern Med
; 174(2): 221-228, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33090877
8.
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
Ann Intern Med
; 174(8): 1118-1125, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33844575
9.
Efficient nonparametric inference on the effects of stochastic interventions under two-phase sampling, with applications to vaccine efficacy trials.
Biometrics
; 77(4): 1241-1253, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32949147
10.
A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation.
J Infect Dis
; 217(5): 693-702, 2018 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29216395
11.
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial.
J Infect Dis
; 217(8): 1280-1288, 2018 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29325070
12.
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.
J Infect Dis
; 215(9): 1376-1385, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28199679
13.
Power/sample size calculations for assessing correlates of risk in clinical efficacy trials.
Stat Med
; 35(21): 3745-59, 2016 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27037797
14.
Sexually transmitted infections amongst men who have sex with men (MSM) in South Africa.
PLOS Glob Public Health
; 3(4): e0001782, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37018240
15.
Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial.
Int J Infect Dis
; 137: 28-39, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37820782
16.
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
Open Forum Infect Dis
; 10(3): ofad069, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895286
17.
Risk of COVID-19 after natural infection or vaccination.
EBioMedicine
; 96: 104799, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37738833
18.
Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine.
NPJ Vaccines
; 8(1): 36, 2023 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36899062
19.
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial.
Sci Transl Med
; 15(692): eade9078, 2023 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37075127
20.
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial.
Viruses
; 15(10)2023 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37896806